Effective MR Molecular Imaging of Triple Negative Breast Cancer With an EDB-Fibronectin-Specific Contrast Agent at Reduced Doses

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.01351
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Molecular Stratification Within Triple-Negative Breast Cancer Subtypes

Scientific Reports
Multidisciplinary
2019English

A Targeted Nanoglobular Contrast Agent From Host-Guest Self-Assembly for MR Cancer Molecular Imaging

Biomaterials
Mechanics of MaterialsBiophysicsBiomaterialsBioengineeringCompositesNanoscienceNanotechnologyCeramics
2016English

Exploring Specific Prognostic Biomarkers in Triple-Negative Breast Cancer

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

Triple-Negative Breast Cancer

2018English

Spectroscopic Photoacoustic Molecular Imaging of Breast Cancer Using a B7-H3-Targeted ICG Contrast Agent

Theranostics
MedicineToxicologyPharmaceuticsPharmacology
2017English

Triple-Negative Breast Cancer: An Unmet Medical Need

Oncologist
Cancer ResearchMedicineOncology
2011English

Molecular Stratification of Triple-Negative Breast Cancers

Oncologist
Cancer ResearchMedicineOncology
2010English

ICAM-1 as a Molecular Target for Triple Negative Breast Cancer

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2014English

Triple Negative Breast Cancer: Breast Cancer Research in Evolution

Breast Disease
MedicineCancer ResearchOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy